Vice President Real World Data, Pfizer
Marc L. Berger, M.D. is Vice President, Real World Data and Analytics at Pfizer. During his career, he has held a variety of leadership positions at OptumInsight, Eli Lilly and Company, and Merck & Co., Inc. His professional activities have included serving on the Medicare Evidence Development & Coverage Advisory Committee (MedCAC), the board of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the steering committee for the Agency for Health Care Research and Quality (AHRQ) Centers for Research and Education on Therapeutics (CERTs). He also co-chaired the ISPOR Taskforce on Prospective Observational Studies for Comparative Effectiveness Research and currently chairs the AMCP-ISPOR-NPC Collaborative Initiative Taskforce for the Interpreting Prospective Observational Studies for Health Care Decisions. Marc has written or co-written more than 100 peer-reviewed articles, book chapters, and other publications on a range of topics including health services research, outcomes research, health economics, and health policy.